About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Effect of Growth Hormone in Children With Growth Hormone Deficiency

Effect of Growth Hormone in Children With Growth Hormone Deficiency

NCT00262249·40 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novo Nordisk A/S

Age

3–15

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Clinically suspected GHD
Height \< -2.0 SDS
Serum IGF-I less than or equal to -1.0 SDS
Bone age less than or equal to 9 years for boys and less than or equal to 7 years for girls.
Puberty Tanner Stage I

You may not be if

Previous use of growth hormone
Growth retardation attributable to causes other than GHD (e.g. inborn errors of metabolism, primary bone disease, chromosomal disorders, etc.)
Intrauterine growth retardation: birth weight \< 3rd percentile.
Administration of other growth-altering medications.
Evidence of any malignancy or intracranial tumors.

The record

StatusCompleted

PhasePhase 3

Taking part173

StartedAug 2000

UpdatedJan 18, 2017

Conditions

Growth Hormone Disorder Growth Hormone Deficiency in Children Growth Disorder Idiopathic Short Stature

Where40

Novo Nordisk Investigational Site
Los Angeles, California, United States
Novo Nordisk Investigational Site
Los Angeles, California, United States
Novo Nordisk Investigational Site
Sacramento, California, United States